Mounjaro (tirzepatide) Approval Letter
FDA approved Mounjaro (tirzepatide) injection as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Not legal or medical advice.
This page is for informational purposes only. Always verify the current official source or consult a qualified professional before making compliance, prescribing, purchasing, or clinical decisions. Read full disclaimer.
U.S. Food and Drug AdministrationApproval letterApproved
- Docket / Citation
- NDA 215866
- Published
- 2022-05-13
- Effective
- 2022-05-13